Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology Society
Authors:
- Vera Luiza CapelozziVera Luiza Capelozzi
- Timothy Craig AllenTATimothy Craig Allen
- Mary Beth BeasleyMBMary Beth Beasley
- Philip T. CaglePCPhilip T. Cagle
- Don GuineeDGDon Guinee
- Lida P. HaririLHLida P. Hariri
- Aliya N. HusainAHAliya N. Husain
- Deepali JainDJDeepali Jain
- Sylvie LantuejoulSLSylvie Lantuejoul
- Brandon T. LarsenBLBrandon T. Larsen
- Ross MillerRMRoss Miller
- Mari Mino-KenudsonMMMari Mino-Kenudson
- 1 December 2017
- journal article
- research article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 141 (12) , 1719-1727
Abstract
Acute respiratory distress syndrome (ARDS) is a multifactorial syndrome with high morbidity and mortality rates, characterized by deficiency in gas exchange and lung mechanics that lead to hypoxemia, dyspnea, and respiratory failure. Histologically, ARDS is characterized by an acute, exudative phase, combining diffuse alveolar damage and noncardiogenic edema, followed by a later fibroproliferative phase. Despite an enhanced understanding of ARDS pathogenesis, the capacity to predict the development of ARDS and to risk-stratify patients with the disease remains limited. Biomarkers may help to identify patients at the greatest risk of developing ARDS, to evaluate response to therapy, to predict outcome, and to improve clinical trials. The ARDS pathogenesis is presented in this article, as well as concepts and information on biomarkers that are currently used clinically or are available for laboratory use by academic and practicing pathologists and the developing and validating of new assays, focusing on the assays' major biologic roles in lung injury and/or repair and to ultimately suggest innovative, therapeutic approaches.Keywords
This publication has 70 references indexed in Scilit:
- Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndromeCritical Care, 2013
- Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Biomarkers of acute lung injury: worth their salt?BMC Medicine, 2011
- Biomarkers in Acute Lung Injury—Marking Forward ProgressCritical Care Clinics, 2011
- Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung InjuryCritical Care Clinics, 2011
- Deletion of Pten Expands Lung Epithelial Progenitor Pools and Confers Resistance to Airway InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Determining the aetiology of pulmonary oedema by the oedema fluid-to-plasma protein ratioEuropean Respiratory Journal, 2009
- Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injuryThorax, 2008
- The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factorThorax, 2007
- Higher urine desmosine levels are associated with mortality in patients with acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006